<DOC>
	<DOCNO>NCT00115362</DOCNO>
	<brief_summary>The purpose study investigate whether Efexor ( venlafaxine ) effective treatment functional dyspepsia .</brief_summary>
	<brief_title>Serotonin Effect Functional Dyspepsia</brief_title>
	<detailed_description>BACKGROUND : A good 60 % patient present upper abdominal complaint functional dyspepsia . Usually , acid-suppressive drug give first-line therapy upper gastrointestinal symptom . However , result often satisfy symptom persist . Since many patient functional gastrointestinal disease anxious depress comparison healthy control , several study investigate use antidepressant agent patient . Although many study underpowered , promise result obtain tricyclic antidepressant mianserin patient irritable bowel syndrome . There still need placebo control study antidepressant patient functional dyspepsia . OBJECTIVE : To investigate effectiveness venlafaxine , selective serotonin norepinephrine reuptake inhibitor , treatment patient functional dyspepsia . STUDY DESIGN : A randomized , double blind , placebo control trial . STUDY POPULATION : Consecutive patient persistent upper GI symptom without abnormality upper gastrointestinal endoscopy . PRIMARY ENDPOINTS : Upper gastrointestinal symptom absence 6 week treatment . SECONDARY ENDPOINTS : - Anxiety depression venlafaxine treatment ; - Health related quality life venlafaxine treatment ; - The association serotonin transporter protein 5-HT receptor polymorphism efficacy venlafaxine . STUDY PROCEDURE : A venous blood sample collect 10ml EDTA-tube . Then , subject randomize treatment Efexor XR ( first last two week 75 mg 1dd third fifth week 75 mg 2dd ) identical placebo 8 week . Before start finishing treatment , patient ask fill questionnaire intensity gastrointestinal complaint , current quality life anxiety depression .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Serotonin Agents</mesh_term>
	<criteria>Persistent upper gastrointestinal symptom ; Absence serious organic cause complaint previous upper gastrointestinal endoscopy ( include gastric ulcer , carcinoma , oesophageal reflux disease , portal hypertension , hernia hiatus &gt; 2 cm severe gastritis ) ; Over 18 year age ; Written inform consent . History bipolar disorder ; Contraindication venlafaxine ; Current plan pregnancy lactation ; Diagnosed alcoholism , anorexia nervosa bulimia ; Current recent ( within last two week ) use selective serotonin reuptake inhibitor ( SSRI ) MAOinhibitor ; Any condition circumstance , opinion investigator physician , would compromise subject 's successful participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>functional dyspepsia ;</keyword>
	<keyword>Serotonin Uptake Inhibitors ;</keyword>
	<keyword>Antidepressive Agents .</keyword>
</DOC>